APA (7th ed.) Citation

Ribeiro, S., Garrido, P., Fernandes, J., Vala, H., Rocha-Pereira, P., Costa, E., . . . Santos-Silva, A. (2020). Renal risk-benefit determinants of recombinant human erythropoietin therapy in the remnant kidney rat model - hypertension, anaemia, inflammation and drug dose.

Chicago Style (17th ed.) Citation

Ribeiro, Sandra, Patrícia Garrido, João Fernandes, Helena Vala, Petronila Rocha-Pereira, Elísio Costa, Luís Belo, Flávio Reis, and Alice Santos-Silva. Renal Risk-benefit Determinants of Recombinant Human Erythropoietin Therapy in the Remnant Kidney Rat Model - Hypertension, Anaemia, Inflammation and Drug Dose. 2020.

MLA (8th ed.) Citation

Ribeiro, Sandra, et al. Renal Risk-benefit Determinants of Recombinant Human Erythropoietin Therapy in the Remnant Kidney Rat Model - Hypertension, Anaemia, Inflammation and Drug Dose. 2020.